MarketScreener Editorial Features EyePoint Pharmaceuticals, Inc. Deutsche Boerse AG
Equities
PV3B
US30233G2093
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.111 EUR | +0.19% |
|
+3.20% | -63.14% |
06-26 | EyePoint Pharmaceuticals, Inc. Highlights Duravuyu Clinical and Regulatory Progress and Pipeline Innovation At R&D Day 2024 | CI |
06-26 | Transcript : EyePoint Pharmaceuticals, Inc. - Special Call |
- Stock Market
- Equities
- EYPT Stock
- PV3B Stock
- News EyePoint Pharmaceuticals, Inc.
- MarketScreener Editorial Features